1. Pediatric drugs—A review of commercially available oral formulations;Strickley;J Pharm Sci,2008
2. ICH E11. Clinical investigation of medicinal products in the paediatric population. CPMP/ICH/2711/99.
3. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs;Lam;Pharmacotherapy,2011
4. Extemporaneous formulations: Problems and solutions;Woods;Paediatr Perinatal Drug Ther,1997
5. Allen LV Jr., Erickson MA III. Stability of extemporaneously prepared pediatric formulations using Ora-Plus with Ora-Sweet and Ora-Sweet SF—Part I. Secundum Artem. Vol. V. Minneapolis, Minnesota: Paddock Laboratories. Accessed, at: http://www.paddocklabs.com/secundum_artem.html.